Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Investing Activities: 2013-2024

Historic Cash from Investing Activities for Soleno Therapeutics (SLNO) over the last 11 years, with Dec 2024 value amounting to -$225.7 million.

  • Soleno Therapeutics' Cash from Investing Activities rose 159.20% to $103,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $528,000, marking a year-over-year increase of 171.64%. This contributed to the annual value of -$225.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Soleno Therapeutics reported Cash from Investing Activities of -$225.7 million as of FY2024, which was down 1,735,915.38% from -$13,000 recorded in FY2022.
  • Soleno Therapeutics' 5-year Cash from Investing Activities high stood at -$7,000 for FY2020, and its period low was -$225.7 million during FY2024.
  • For the 2-year period, Soleno Therapeutics' Cash from Investing Activities averaged around -$112.8 million, with its median value being -$112.8 million (2022).
  • Per our database at Business Quant, Soleno Therapeutics' Cash from Investing Activities tumbled by 214.29% in 2021 and then skyrocketed by 40.91% in 2022.
  • Yearly analysis of 4 years shows Soleno Therapeutics' Cash from Investing Activities stood at -$7,000 in 2020, then plummeted by 214.29% to -$22,000 in 2021, then spiked by 40.91% to -$13,000 in 2022, then reached -$225.7 million in 2024.